Transluminal Technologies, LLC

Transluminal Technologies, LLC

Transluminal Technologies focuses on the development of novel, minimally invasive cardiovascular devices which utilize the company’s proprietary absorbable biometals. Transluminal Technologies is ISO 13485 certified. The Transluminal team is composed of internationally renowned cardiologists, paired with seasoned, patent-holding engineers. With proven track records of successful entrepreneurship, the development team members combine established relationships within the medical device industry, business acumen, and deep product development expertise to deliver world-class interventional cardiology device designs. The market for global interventional cardiology devices will reach USD 25.16 billion by 2020, according to a new report.1 Increasing prevalence of cardiovascular diseases coupled with adoption of minimally invasive surgeries is expected to boost the interventional cardiology device market over the forecast period.

Company details

2930 E Genesee St,Syracuse,13224

Find locations servedoffice locations

Business Type:
Manufacturer
Industry Type:
Medical Equipment
Market Focus:
Globally (various continents)

Contact supplier

Drop file here or browse